Avid Bioservices Inc (CDMO)

[stockaxe]

In my opinion, given the share price retreat, there is a significant risk that one of the larger players takes advantage and offers a large premium to today's price, but still a significant discount to what it is worth and where it traded last year. $22 is abysmal. I won't vote in favor of any deal that is less than $35. This is a growing industry and investors are much better off just waiting a few years for the capacity to fill up before they give shares away cheaply.